Established in December, 2005, Chengdu Kanghong Biological Science & Technology Co. Ltd. is specialized in research and development of biotechnology pharmacy. Through international cooperation, it succeeds in building three 3 product innovative technical platforms leading domestically and keeps pace with international development (protein genetic engineering, gene treatment and tumor vaccine) and 3 industrialized technical platforms (large-scale virus production and purification, large-scale protein and antibody production and purification, tumor vaccine production technical platform). The successful establishment of these technique platforms bring forth three class I national registered biotechnical pharmacy leading internationally owning to its independent intellectual property. They are individualized tumor vaccine (KH901), ophthalmologic genetic engineering pharmacy (KH902) and tumor genetic engineering pharmacy (KH903).